| Attribute |
Value |
| 52 Week Change |
-0.88799286 |
| Address1 |
2,401 S. Foothill Drive |
| Address2 |
Suite D |
| All Time High |
929.7 |
| All Time Low |
0.906 |
| Ask |
16.0 |
| Ask Size |
1 |
| Audit Risk |
8 |
| Average Daily Volume10 Day |
352,480 |
| Average Daily Volume3 Month |
335,601 |
| Average Volume |
335,601 |
| Average Volume10Days |
352,480 |
| Beta |
2.904 |
| Bid |
1.06 |
| Bid Size |
1 |
| Board Risk |
10 |
| Book Value |
2.606 |
| City |
Salt Lake City |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
7 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.065 |
| Current Ratio |
1.813 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.25 |
| Day Low |
1.0601 |
| Debt To Equity |
14.153 |
| Display Name |
Co-Diagnostics |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,786,653,000 |
| Earnings Call Timestamp Start |
1,786,653,000 |
| Earnings Timestamp |
1,786,651,200 |
| Earnings Timestamp End |
1,794,859,200 |
| Earnings Timestamp Start |
1,794,859,200 |
| Ebitda |
-29,090,594 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.165 |
| Enterprise To Revenue |
6.665 |
| Enterprise Value |
4,808,235 |
| Eps Forward |
-0.83 |
| Eps Trailing Twelve Months |
-26.14 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.20294 |
| Fifty Day Average Change |
-0.13793993 |
| Fifty Day Average Change Percent |
-0.114669 |
| Fifty Two Week Change Percent |
-88.799286 |
| Fifty Two Week High |
46.5 |
| Fifty Two Week High Change |
-45.435 |
| Fifty Two Week High Change Percent |
-0.9770968 |
| Fifty Two Week Low |
0.906 |
| Fifty Two Week Low Change |
0.15900004 |
| Fifty Two Week Low Change Percent |
0.17549673 |
| Fifty Two Week Range |
0.906 - 46.5 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,499,866,200,000 |
| Float Shares |
6,134,838 |
| Forward Eps |
-0.83 |
| Forward P E |
-1.2831327 |
| Free Cashflow |
-17,492,616 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
115 |
| Fullday Change |
-0.0050001144 |
| Fullday Change Percent |
-0.46949428 |
| Fullday Price |
1.06 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.43477002 |
| Gross Profits |
313,634 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.02073 |
| Held Percent Institutions |
0.105349995 |
| Implied Shares Outstanding |
6,981,319 |
| Industry |
Medical Devices |
| Industry Disp |
Medical Devices |
| Industry Key |
medical-devices |
| Ipo Expected Date |
2,026-03-11 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,767,312,000 |
| Last Split Factor |
1:30 |
| Long Business Summary |
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah. |
| Long Name |
Co-Diagnostics, Inc. |
| Market |
us_market |
| Market Cap |
7,435,105 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_60358987 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-47,056,372 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
7,609,637 |
| Number Of Analyst Opinions |
1 |
| Open |
1.24 |
| Operating Cashflow |
-27,103,204 |
| Operating Margins |
-37.32466 |
| Overall Risk |
7 |
| Payout Ratio |
0.0 |
| Phone |
801 438 1036 |
| Pre Market Change |
-0.0050001144 |
| Pre Market Change Percent |
-0.46949428 |
| Pre Market Price |
1.06 |
| Pre Market Time |
1,791,964,804 |
| Previous Close |
1.25 |
| Price Hint |
4 |
| Price To Book |
0.40867233 |
| Price To Sales Trailing12 Months |
10.306694 |
| Profit Margins |
0.0 |
| Quick Ratio |
1.293 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.185 |
| Regular Market Change Percent |
-14.8 |
| Regular Market Day High |
1.25 |
| Regular Market Day Low |
1.0601 |
| Regular Market Day Range |
1.0601 - 1.25 |
| Regular Market Open |
1.24 |
| Regular Market Previous Close |
1.25 |
| Regular Market Price |
1.065 |
| Regular Market Time |
1,791,921,601 |
| Regular Market Volume |
481,708 |
| Return On Assets |
-0.59634995 |
| Return On Equity |
-1.74766 |
| Revenue Growth |
0.02 |
| Revenue Per Share |
0.297 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
4 |
| Shares Outstanding |
6,981,319 |
| Shares Percent Shares Out |
0.06 |
| Shares Short |
418,934 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
214,608 |
| Short Name |
Co-Diagnostics, Inc. |
| Short Percent Of Float |
0.061 |
| Short Ratio |
1.73 |
| Source Interval |
15 |
| State |
UT |
| Symbol |
CODX |
| Target High Price |
4.0 |
| Target Low Price |
4.0 |
| Target Mean Price |
4.0 |
| Target Median Price |
4.0 |
| Total Cash |
3,649,632 |
| Total Cash Per Share |
0.584 |
| Total Debt |
1,799,148 |
| Total Revenue |
721,386 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-26.14 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.550085 |
| Two Hundred Day Average Change |
-1.485085 |
| Two Hundred Day Average Change Percent |
-0.5823668 |
| Type Disp |
Equity |
| Volume |
481,708 |
| Website |
https://co-dx.com |
| Zip |
84,109 |